Home › Crohn's Disease › Tennessee
Pag-aaral pangklinika para sa Crohn's Disease sa Tennessee
10 pag-aaral para sa Crohn's Disease ang naghahanap ng mga kalahok sa mga site sa Tennessee.
Mga Lungsod sa Tennessee
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Vanderbilt Inflammatory Bowel Disease Clinic ( Site 5049), Nashville
- Quality Medical Research ( Site 5114), Nashville
Nagre-recruitPhase 3
Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Gastrointestinal Associates - Knoxville - Dowell Springs Boulevard /ID# 283861, Knoxville
- Gastro One - Memphis /ID# 283948, Memphis
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Tri-Cities Gastroenterology, Kingsport
Nagre-recruitPhase 4
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06581328Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- GI associates of Northeast Tennessee /ID# 265567, Johnson City
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06548542Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Gastroenterology Center Of The Midsouth, Cordova
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06937099An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Tri-Cities Gastroenterology-Site Number: 8400076, Kingsport
Nagre-recruitPhase 3
Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07184931A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Gastrointestinal Associates of Northeast Tennessee, Johnson City
Nagre-recruitPhase 2
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06226883A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Gastro One, Cordova
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07577843Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Vanderbilt University Medical Center, Nashville
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Abr 27, 2026 · NCT06456593A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Cordova
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Mar 12, 2026 · NCT07113522Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.